These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 32472085

  • 1. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
    Ozono Y, Shide K, Kameda T, Kamiunten A, Tahira Y, Sekine M, Akizuki K, Nakamura K, Iwakiri H, Sueta M, Hidaka T, Kubuki Y, Yamamoto S, Hasuike S, Sawaguchi A, Nagata K, Shimoda K.
    Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
    [Abstract] [Full Text] [Related]

  • 2. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T, Verstovsek S, Harris DM, Veletic I, Zhang X, Post SM, Bueso-Ramos CE, Estrov Z.
    PLoS One; 2019 Feb; 14(9):e0222912. PubMed ID: 31569199
    [Abstract] [Full Text] [Related]

  • 3. TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis.
    Varricchio L, Iancu-Rubin C, Upadhyaya B, Zingariello M, Martelli F, Verachi P, Clementelli C, Denis JF, Rahman AH, Tremblay G, Mascarenhas J, Mesa RA, O'Connor-McCourt M, Migliaccio AR, Hoffman R.
    JCI Insight; 2021 Sep 22; 6(18):. PubMed ID: 34383713
    [Abstract] [Full Text] [Related]

  • 4. Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis.
    Verstovsek S, Manshouri T, Pilling D, Bueso-Ramos CE, Newberry KJ, Prijic S, Knez L, Bozinovic K, Harris DM, Spaeth EL, Post SM, Multani AS, Rampal RK, Ahn J, Levine RL, Creighton CJ, Kantarjian HM, Estrov Z.
    J Exp Med; 2016 Aug 22; 213(9):1723-40. PubMed ID: 27481130
    [Abstract] [Full Text] [Related]

  • 5. Hmga2 promotes the development of myelofibrosis in Jak2V617F knockin mice by enhancing TGF-β1 and Cxcl12 pathways.
    Dutta A, Hutchison RE, Mohi G.
    Blood; 2017 Aug 17; 130(7):920-932. PubMed ID: 28637665
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of ALK5 inhibition in myelofibrosis.
    Yue L, Bartenstein M, Zhao W, Ho WT, Han Y, Murdun C, Mailloux AW, Zhang L, Wang X, Budhathoki A, Pradhan K, Rapaport F, Wang H, Shao Z, Ren X, Steidl U, Levine RL, Zhao ZJ, Verma A, Epling-Burnette PK.
    JCI Insight; 2017 Apr 06; 2(7):e90932. PubMed ID: 28405618
    [Abstract] [Full Text] [Related]

  • 7. Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.
    Maekawa T, Kato S, Kawamura T, Takada K, Sone T, Ogata H, Saito K, Izumi T, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Horiuchi T, Hikota-Saga R, Endo-Umeda K, Uno S, Osawa Y, Kobayashi A, Kobayashi S, Sato K, Hashimoto M, Suzu S, Usuki K, Morishita S, Araki M, Makishima M, Komatsu N, Kimura F.
    Blood; 2019 Sep 05; 134(10):814-825. PubMed ID: 31270105
    [Abstract] [Full Text] [Related]

  • 8. Adhesion to fibronectin via α5β1 integrin supports expansion of the megakaryocyte lineage in primary myelofibrosis.
    Matsuura S, Thompson CR, Ng SK, Ward CM, Karagianni A, Mazzeo C, Malara A, Balduini A, Ravid K.
    Blood; 2020 Jun 18; 135(25):2286-2291. PubMed ID: 32294178
    [Abstract] [Full Text] [Related]

  • 9. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ, Lewandowski D, Martelli F, Marra M, Zingariello M, Sancillo L, Rana RA, Migliaccio AR.
    Stem Cells; 2016 Jan 18; 34(1):67-82. PubMed ID: 26439305
    [Abstract] [Full Text] [Related]

  • 10. Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm.
    Yang Y, Akada H, Nath D, Hutchison RE, Mohi G.
    Blood; 2016 Jun 30; 127(26):3410-23. PubMed ID: 27081096
    [Abstract] [Full Text] [Related]

  • 11. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
    Bock O, Höftmann J, Theophile K, Hussein K, Wiese B, Schlué J, Kreipe H.
    Am J Pathol; 2008 Apr 30; 172(4):951-60. PubMed ID: 18349123
    [Abstract] [Full Text] [Related]

  • 12. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
    Wen QJ, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider RK, Breyfogle LJ, Schultz R, Gilles L, Koppikar P, Abdel-Wahab O, Pardanani A, Stein B, Gurbuxani S, Mullally A, Levine RL, Tefferi A, Crispino JD.
    Nat Med; 2015 Dec 30; 21(12):1473-80. PubMed ID: 26569382
    [Abstract] [Full Text] [Related]

  • 13. GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes.
    Manshouri T, Veletic I, Li P, Yin CC, Post SM, Verstovsek S, Estrov Z.
    Cell Death Dis; 2022 May 20; 13(5):481. PubMed ID: 35595725
    [Abstract] [Full Text] [Related]

  • 14. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
    Gleitz HFE, Dugourd AJF, Leimkühler NB, Snoeren IAM, Fuchs SNR, Menzel S, Ziegler S, Kröger N, Triviai I, Büsche G, Kreipe H, Banjanin B, Pritchard JE, Hoogenboezem R, Bindels EM, Schumacher N, Rose-John S, Elf S, Saez-Rodriguez J, Kramann R, Schneider RK.
    Blood; 2020 Oct 29; 136(18):2051-2064. PubMed ID: 32726410
    [Abstract] [Full Text] [Related]

  • 15. [The role of fibrocytes in myelofibrosis and fibrocyte regulation as a novel treatment approach].
    Maekawa T, Kato S, Kimura F.
    Rinsho Ketsueki; 2020 Oct 29; 61(1):3-10. PubMed ID: 32023599
    [Abstract] [Full Text] [Related]

  • 16. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
    Gong XB, Zhang XH, Lu XG, Tang QS, Gao X, Yang J.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan 29; 33(1):25-30. PubMed ID: 22575188
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J.
    Exp Hematol; 2006 Dec 29; 34(12):1617-23. PubMed ID: 17157157
    [Abstract] [Full Text] [Related]

  • 18. The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
    Uchiyama T, Kawabata H, Miura Y, Yoshioka S, Iwasa M, Yao H, Sakamoto S, Fujimoto M, Haga H, Kadowaki N, Maekawa T, Takaori-Kondo A.
    Cancer Med; 2015 Oct 29; 4(10):1558-72. PubMed ID: 26276681
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.
    Rahman MF, Yang Y, Le BT, Dutta A, Posyniak J, Faughnan P, Sayem MA, Aguilera NS, Mohi G.
    Nat Commun; 2022 Sep 13; 13(1):5347. PubMed ID: 36100596
    [Abstract] [Full Text] [Related]

  • 20. Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
    Ciaffoni F, Cassella E, Varricchio L, Massa M, Barosi G, Migliaccio AR.
    Blood Cells Mol Dis; 2015 Mar 13; 54(3):234-41. PubMed ID: 25703685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.